Data are from Price et al 2016 and are freely available, see <http://genomics.lbl.gov/supplemental/bigfit/> or <http://fit.genomics.lbl.gov/>. All data and code for the paper have also been uploaded to figshare (DOI: <https://doi.org/10.6084/m9.figshare.5005004.v1>).

Introduction {#sec001}
============

Gene regulation is a key mechanism used by bacteria to survive in varying environments. The major class of regulators in prokaryotes are transcription factors (TFs), which are proteins that increase or decrease the transcription of their target genes. Transcription factors target specific genes by binding to specific sites near those genes' promoters. Each transcription factor has a specific pattern of DNA sequences that it binds to, called a motif \[[@pone.0178258.ref001]\].

Since the typical bacterial genome encodes over 100 TFs whose targets and functions are not known \[[@pone.0178258.ref002]\], it is critical to study TFs at large scales. Experimentally, TF-target interactions have been predicted by using high-throughput co-expression data \[[@pone.0178258.ref003]\] or by using chromatin immunoprecipitation and related techniques to identify a TF's binding locations on the genome \[[@pone.0178258.ref004]\]. However, co-expression is indirect evidence of a regulatory relationship \[[@pone.0178258.ref001]\] and these predictions are incomplete and have high false positive rates \[[@pone.0178258.ref003]\]. For instance, the context likelihood of relatedness algorithm identified 11% of known interactions at a false positive rate of 40% in *E*. *coli* \[[@pone.0178258.ref003]\]. Location data also has several limitations. First, location data fails to detect some interactions due to inefficient cross-linking at some locations \[[@pone.0178258.ref001]\] or poor TF binding in tested conditions. Second, location data may not imply regulatory relationships, as it may detect binding that does not affect expression \[[@pone.0178258.ref005]\]. Lastly, while genome-wide coexpression is available for over 20 species \[[@pone.0178258.ref006],[@pone.0178258.ref003],[@pone.0178258.ref007]\], to our knowledge large-scale location data is only available for a few bacteria \[[@pone.0178258.ref004],[@pone.0178258.ref008],[@pone.0178258.ref009]\].

Alternatively, TF-target pairs have been predicted using comparative genomics. Comparative genomics methods rely on a key assumption that transcription factor binding sites are more conserved than other intergenic sequences. For example, a known motif for a TF can be used to identify targets of the TF's orthologs by searching for occurrences of the known motif \[[@pone.0178258.ref001]\], using tools such as Patser \[[@pone.0178258.ref010]\]. The identified genes are predicted to be regulated by an ortholog of the TF, especially if multiple orthologous targets have the site. Another approach is to predict new motifs and to search for their associated targets. In order to predict a motif, a training set, composed of upstream regions of potentially co-regulated genes, is collected from multiple orthologous genomes \[[@pone.0178258.ref001]\]. Then, a conserved sequence is identified in the training set using motif discovery algorithms such as MEME \[[@pone.0178258.ref011]\]. The motif is considered reliable if it is conserved across functionally-related genes in multiple genomes. A major challenge in this approach is the association of a motif to the correct TF \[[@pone.0178258.ref001]\]. There are many heuristics for predicting the TF-motif pairs \[[@pone.0178258.ref012]\], but experimental evidence can significantly improve the accuracy \[[@pone.0178258.ref001]\].

RegPrecise provides a manually-curated collection of comparative genomics predictions that associate TFs with motifs and targets \[[@pone.0178258.ref013]\]. These predictions are based on both known and newly predicted motifs. Training sets for motif predictions are mainly composed of genes in a functional pathway \[[@pone.0178258.ref014]\]. Most RegPrecise predictions lack experimental evidence.

Here, we consider the utility of mutant fitness data for statistically validating the computational predictions from RegPrecise. To collect the fitness data, transposon mutant strains, each of which has one transposon insertion in the genome, are grown in a pool of \~40,000--500,000 strains in various conditions. The effect of mutating each gene on growth in each condition is then measured by quantifying the change in abundance of their mutant strains \[[@pone.0178258.ref015]\]. We used fitness data for most genes in 25 bacteria across many conditions (\[[@pone.0178258.ref016]\]; <http://fit.genomics.lbl.gov/>). The fitness patterns of activators and repressors are expected to be positively and negatively correlated with the fitness patterns of their targets \[[@pone.0178258.ref017]\].

In this study, we show that many characterized transcription factors have strongly correlated fitness patterns with a small subset of their targets. As a consequence, we consider a TF-motif association from comparative genomics to be statistically validated if at least one target's fitness pattern is significantly correlated with the TF's pattern. In RegPrecise, we validated 158 TFs in 107 ortholog groups with a 3.0% false discovery rate (FDR). We also classified most of these TFs as activators (124) or repressors (28) based on the sign of their cofitness with their target genes. Thus, the mutant fitness data provides experimental support for the roles of over 100 TFs that were previously predicted by comparative genomics.

Results {#sec002}
=======

Cofitness of transcription factors and their targets {#sec003}
----------------------------------------------------

Activating TF-target pairs are expected to have strong positive cofitness, where cofitness is the correlation between the fitness patterns of two genes. If a transposon is inserted into an activator, then the target gene's expression would be reduced. If a transposon is inserted into a target gene, then there would no longer be functional transcripts of the target gene. Since the amount of functional transcript of the target is reduced under both scenarios, the activator and its targets are expected to have positively correlated fitness patterns. In contrast, repressors are expected to be anti-cofit (have negative cofitness) with their targets. If a transposon is inserted into a repressor, then the target gene expression would be elevated. If a transposon is inserted into a target gene, then there would no longer be functional transcripts of the target gene. If elevated and reduced levels of functional target transcripts lead to opposite phenotypes, then the two fitness patterns are expected to be negatively correlated. Similarly, TF-target pairs are expected to have extreme ranks in cofitness and anti-cofitness. Cofitness rank is the rank of TF-target cofitness relative to the TF's cofitness with other genes in the genome, where the most positive cofitness has the top rank. Anti-cofitness rank is the ranking in reverse order.

In *E*. *coli*, transcription factors do tend to be highly cofit or anti-cofit with at least one of their experimentally-identified targets. For example, DcuR is an activating transcription factor that regulates genes involved in C4-dicarboxylate metabolism, and it has high cofitness with one of its targets, *dctA*. As shown in [Fig 1A](#pone.0178258.g001){ref-type="fig"}, *dcuR* and *dctA* are important for aerobic growth with dicarboxylates (malate or succinate) as the carbon source, as expected. More importantly, *dcuR*'s fitness pattern closely matches the fitness pattern of *dctA* ([Fig 1A](#pone.0178258.g001){ref-type="fig"}), with cofitness of 0.97 and rank 2 out of 3,788 ([Fig 1B and 1C](#pone.0178258.g001){ref-type="fig"}). Other targets of DcuR have weak cofitness and ranks ([Fig 1C](#pone.0178258.g001){ref-type="fig"}). For example, fumarate reductase (*fdrABCD*) is only expected to be on important under anaerobic conditions, and its expression can be induced by another regulator besides DcuR (namely Fnr), so it's not surprising that it has a different fitness pattern than *dcuR*. In contrast, *treR*, which represses genes involved in trehalose transport and degradation, has a fitness pattern that seems to be the opposite of the fitness pattern of its target, *treB*. As shown in [Fig 1D](#pone.0178258.g001){ref-type="fig"}, *treR* and its targets have strong phenotypes when trehalose is the carbon source, as expected. More importantly, *treR* and *treB* have strong negative cofitness of -0.59 and a top anti-cofitness rank of 1 ([Fig 1C](#pone.0178258.g001){ref-type="fig"}). TreR's other target, *treC*, has weak cofitness and rank ([Fig 1C and 1D](#pone.0178258.g001){ref-type="fig"}); even though *treBC* forms an operon, the fitness pattern of *treC* seems to be more complex because, aside from its role in trehalose utilization, TreC can modify maltose \[[@pone.0178258.ref018]\].

![Examples of fitness patterns of experimentally-identified TF-target pairs in *E*. *coli*.\
(A) Heatmap showing the fitness values of the activator *dcuR* and its targets across 162 experiments. Gene fitness is a log~2~ ratio that describes the change in abundance of strains with a transposon inside the gene over the course of pooled incubation \[[@pone.0178258.ref015]\]. Positive fitness suggests that the gene is detrimental to growth in the condition, while negative fitness suggests that the gene is important for growth. The labels above and below the heatmap describe the growth conditions. (B) Scatter plot of the fitness values of *dcuR* and *dctA*. Lines show *x = 0*, *y = 0*, and *x = y*. (C) Distribution of cofitness values for *dcuR* and *treR*. Each panel shows the cofitness of the transcription factor with 3,788 genes in the *E*. *coli* genome that have fitness data (x axis). The *y* axis is random. (D) Heatmap showing the fitness values of the *treR* repressor and its targets across 162 experiments.](pone.0178258.g001){#pone.0178258.g001}

More broadly, we examined the cofitness of all TF-target pairs that have been identified experimentally in E. coli \[[@pone.0178258.ref019]\]. TFs that are both activators and repressors were excluded to avoid ambiguous cases, which left 44 activating TFs and 57 repressing TFs. As shown in [Fig 2A](#pone.0178258.g002){ref-type="fig"}, TF-target pairs are highly enriched in strong positive cofitness (or anti-cofitness) relative to shuffled pairs. For example, cofitness above 0.5 is enriched in activating TF-target pairs by 15-fold, while anti-cofitness under -0.5 is enriched in repressing TF-target pairs by over 21-fold. [Fig 2B](#pone.0178258.g002){ref-type="fig"} shows that cofitness ranks of 1--50 are enriched in activating pairs by 10-fold, while anti-cofitness ranks of 1--50 are enriched in repressors by 4-fold.

![Distribution of cofitness and cofitness ranks in experimentally-identified TF-target pairs in *E*. *coli*.\
(A) The distribution of cofitness values for activating TF-target pairs, repressing TF-target pairs, and shuffled pairs. The distributions were smoothed using gaussian kernel density estimates. (B) The distribution of cofitness ranks for activating TF-target pairs, repressing TF-target pairs, and shuffled pairs. On the right side, ranks for anti-cofitness are shown with negative numbers, so that the most anti-cofit pair has *x = -1*. The proportion of pairs within each window of 10 cofitness ranks is plotted.](pone.0178258.g002){#pone.0178258.g002}

Statistical approach {#sec004}
--------------------

Applying the above observations, we formulated a method to statistically validate TF-motif predictions from comparative genomics. It is useful to test these predictions at the motif level for two reasons. First, the predictions are motif-based, and the association of a TF with a motif is a major source of uncertainty in comparative genomics predictions. Second, the transcription factor may be cofit with a subset of its targets, as we observed for the characterized regulators *dcuR* and *treR*. [Fig 3](#pone.0178258.g003){ref-type="fig"} demonstrates this trend for several other characterized transcription factors from *E*. *coli*. For this reason, the method validates TF-motif predictions based on the predicted target that is most strongly cofit or anti-cofit with the TF.

![Distribution of cofitness values for four experimentally characterized transcription factors in *E*. *coli*.\
Each panel shows the cofitness of the transcription factor with all other 3,788 genes in the *E*. *coli* genome with fitness data (x axis). The y axis is random.](pone.0178258.g003){#pone.0178258.g003}

The method uses cofitness rank in addition to cofitness, since the distribution of cofitness varies widely among TFs ([Fig 3](#pone.0178258.g003){ref-type="fig"}). In fact, the standard deviation of the cofitness distribution varies from 0.08 to 0.31 among the experimentally-characterized TFs in *E*. *coli*. As a result, it is important to look at the cofitness of the TF-target pairs relative to the TF's cofitness with other genes. For example, in [Fig 3](#pone.0178258.g003){ref-type="fig"}, the cofitness value of 0.61 for *deoR* and its most cofit target seems significant, but such a cofitness would be less convincing for *metR*. Of the 97 characterized TFs in *E*. *coli* that have significant phenotypes (at a false discovery rate under 5%; Price et al., 2016), 64 (66%) have highly-ranked cofitness or anti-cofitness (rank 1--50) with at least one target.

To test whether a TF-motif association is significantly supported by the fitness data, we use a hypothesis test that is based on the top target's rank. By transforming the top target's rank into a *p* value, we can distinguish statistically-validated cases from ambiguous cases. The null and alternate hypotheses state that the TF is not and is associated with the motif, respectively. Under the null hypothesis, any cofitness between the TF and a target is due to random chance; more precisely, the cofitness of the TF with its predicted targets is assumed to follow the same distribution as for a random sample of genes. So, our primary test's *p* value is the probability that a random sample of *T* genes would have a top (anti-)cofitness rank as extreme as the observed value, where *T* is the number of TF's targets not including the TF. Here, we use cofitness ranks that are corrected for a bias, in which closely located gene pairs tend to have slightly higher cofitness (see [Methods](#sec012){ref-type="sec"}). We also do a second test to ensure that the cofitness (or anti-cofitness) of the top target is statistically significant, after correcting for the number of targets. Intuitively, if a TF and its top target have weak cofitness, then we would not consider the TF's validation convincing, even if the rank is high. Finally, we only conduct these tests for TFs that have a significant phenotype in at least one condition (false discovery rate under 5%; \[[@pone.0178258.ref016]\]). Again, the TF's validation would not be convincing if the TF's phenotypes are very weak. Putting these three requirements together, we consider a TF to be statistically validated if it has a significant phenotype and if both the rank-based and cofitness-based tests give P ≤ 0.01.

Statistical validation of RegPrecise predictions {#sec005}
------------------------------------------------

The hypothesis test was applied to the RegPrecise predictions, but since predictions are not available for 17 of the 25 bacteria with fitness data, we tested orthologous predictions for those organisms. An orthologous prediction is a pair of genes that are orthologous to a TF and a target in an original prediction, where the motif of the original prediction exists near the target's ortholog (see [Methods](#sec012){ref-type="sec"}). In RegPrecise, we tested 479 TFs and we statistically validated at least one target for 158 TFs in 107 ortholog groups at a false discovery rate of 3.0%. (The FDR was estimated from the expected false positive rate \* cases tested / positive cases = 0.01 \* 479 / 158 = 0.030.) The validated predictions are listed in [S1](#pone.0178258.s001){ref-type="supplementary-material"} and [S2](#pone.0178258.s002){ref-type="supplementary-material"} Tables. Validated TFs are involved in a variety of pathways, as summarized in [Fig 4](#pone.0178258.g004){ref-type="fig"}.

![Summary of statistically validated RegPrecise predictions.\
If multiple ortholog groups with the same TF name were validated, the number of validated ortholog groups is noted. An ortholog group is a group of orthologous TFs from closely related organisms with a conserved motif.](pone.0178258.g004){#pone.0178258.g004}

Sources of false positives {#sec006}
--------------------------

Although our statistical test is stringent enough to obtain a low rate of false positives due to random correlations, false positives could also arise from other sources. The most prominent source is polar effects, where an insertion in a gene leads to transcription termination and reduced expression of downstream genes. Polar effects on a gene would cause positive cofitness between the gene and its co-transcribed genes, leading to false validations by positive cofitness. In particular, if a TF is co-transcribed with another gene and does not regulate the operon, then the TF may be falsely validated due to polar effects. TF predictions that are potentially affected by polar effects are more likely to be validated due to positive cofitness than other predictions (36% vs 20%) and this difference is statistically significant (16% ± 8%, 95% CI). As a control, we also examined the rate of validation by anti-cofitness and found no effect of co-transcription (a difference of -3% ± 4%, 95% CI). Thus, a significant fraction of predictions that are potentially affected by polar effects may be falsely validated. However, analysis of known TFs in *E*. *coli* suggests that only a small subset of TFs experience significant polar effects. Of 14 pairs of *E*. *coli* TFs that have significant phenotypes and have a potential polar effect (have a co-transcribed adjacent gene that is not a target), five pairs had a cofitness rank of 1--50 (*ompR-envZ*, *yehT-yehU*, *dcuR-dcuS*, *basR-basS*, and *uhpA-uhpB*). However, since all five of these pairs are histidine kinase-response regulator pairs and are thus expected to be cofit, they do not necessarily indicate polar effects. Overall, for 65 of the positively validated TFs (50%), they or their orthologous TFs are validated by targets that are not in the same operon as the TF.

Secondly, complex regulatory networks could lead to false positives. For example, if a TF regulates another TF, the first TF may be cofit with the second TF. In this scenario, the motif for the first TF might well be misassigned to the second TF because the first TF's motif occurs upstream of the second TF, and the cofitness might appear to validate the second TF with the first TF as a target. Although the majority of bacterial TFs do not regulate other TFs, a significant minority do: in *E*. *coli*, 43% of characterized TFs regulate another TF \[[@pone.0178258.ref019]\]. Nevertheless, false positives due to regulation by another TF seem to be uncommon: of 21 characterized TFs in *E*. *coli* that are "validated" by the fitness data and our statistical approach, only one TF is more cofit or anti-cofit with another TF than with their best target (*marR* is more cofit with *acrR*, which regulates *marR*). Another issue is that the first TF might be cofit with its indirect targets (genes that are regulated by the second TF). If the motif for the second TF had, for some reason, been erroneously associated with the first TF, then our approach might (incorrectly) validate that association. Of 18 TFs that regulate other TFs and have significant phenotypes, there were 3 cases where the TF was more cofit with an indirect target than with the any direct target, and for two of these TFs (*rcdA* and *stpA*), the indirect target had a high rank (in the top 50).

Prediction of regulatory sign {#sec007}
-----------------------------

The method can also be used to predict the sign of the regulation. If statistically validated due to cofitness, then the TF is most likely an activator. If statistically validated due to anti-cofitness, then it is most likely a repressor. For known transcription factors in *E*. *coli*, this approach is mostly accurate. For this analysis, we excluded TFs that are both activators and repressors, as either prediction would be accurate. (Of the characterized TFs in *E*. *coli*, 23% are activators, 36% are repressors, and 41% are both activators and repressors \[[@pone.0178258.ref019]\].) Of the 9 remaining TFs from *E*. *coli* that we "validated" by positive cofitness, 8 are activators. And all 3 of the remaining *E*. *coli* TFs that were "validated" by anti-cofitness are repressors. In addition, the misclassified regulator, PuuR, can be explained by polar effects. Lastly, there were 5 ambiguous cases (AcrR, CytR, DeoR, DsdC, GlcC), where the TF was "validated" for both cofitness and anti-cofitness. This seems to happen because two target genes have negatively-correlated phenotypes, so that the TF is cofit with one target and anti-cofit with the other.

Using this approach, we predicted the signs of validated TFs from RegPrecise: 124 activators, 28 repressors, and 6 ambiguous. In some cases, the sign suggested by the cofitness data conflicts the annotation in RegPrecise. For example, MalR, which is in the LacI family, is annotated as a repressor. To our knowledge, there is no experimental evidence of the regulational sign of MalR or its orthologs. However, *malR*'s fitness pattern is strongly correlated with the fitness pattern of *malT* (*Shew_1874*) in *Shewanella loihica* with cofitness of 0.94 and rank of 1, as demonstrated in [Fig 5](#pone.0178258.g005){ref-type="fig"}. Similar fitness patterns are also seen in *Shewanella* sp. ANA-3 and *Shewanella amazonensis*. Predictions in all three organisms are not affected by polar effects. In addition, MalR binds over 300 basepairs upstream of the transcription start site of its target, *malT* \[[@pone.0178258.ref020]\], as is often observed with activators \[[@pone.0178258.ref001]\]. Thus, it seems likely that the regulational sign of MalR is misannotated in RegPrecise, and it is actually an activator, at least in the presence of maltose. Fitness data also suggest that SO4705 (from *Shewanella oneidensis*, *Shewanella* sp. ANA-3, *Shewanella amazonensis*), PckR (from *Sinorhizobium meliloti*), SdaR (from *Shewanella oneidensis*), and ModE2 (from *Desulfovibrio vulgaris*) are activators, contrary to their annotations. These TFs are not affected by polar effects. However, for SO4705, the binding sites are very close to or downstream of the transcription start sites of the targets \[[@pone.0178258.ref020]\], which suggests that SO4705 may yet be a repressor.

![Fitness pattern of *malR* in *Shewanella loihica*.\
(A) Heatmap showing fitness values of *malR* and its targets across 160 experiments. The labels above and below the heatmap are conditions. (B) Distribution of *malR*'s cofitness with all other 3,008 genes in the *Shewanella loihica* genome with fitness data (x axis). The y axis is random.](pone.0178258.g005){#pone.0178258.g005}

Application of the approach to coexpression data {#sec008}
------------------------------------------------

To our knowledge, coexpression has not been used to statistically validate regulatory predictions in bacteria at a large scale. We tested our approach on coexpression data from *E*. *coli* and *Shewanella oneidensis* in the Many Microbe Microarrays Database \[[@pone.0178258.ref021]\]. First, we tested characterized TFs in *E*. *coli* with at least one target that's not co-transcribed with the TF. We "validated" these TFs based on their coexpression with a target in a different operon. Of 171 such TFs with coexpression data, 16 of them were validated by coexpression with a false discovery rate (FDR) of 10.6%. For comparison, of 89 TFs with a significant phenotype, 17 were validated by cofitness at a 5.2% FDR. Of the 89 TFs with both a significant phenotype and coexpression data, only four (*dsdC*, *galS*, *malT*, and *puuR*) are validated by both methods, which suggests that the two validation methods are complementary. Second, we tested our approach on TFs from *Shewanella oneidensis* that have predictions from RegPrecise. Of 50 TFs tested, we validated 5 TFs at 10.0% FDR.

Coexpression seems to give a weaker signal than cofitness, as indicated by the higher FDRs. TFs often lack strong coexpression with any of their targets. For example, of 13 characterized TFs in *E*. *coli* that were "validated" by cofitness but not by coexpression, 12 TFs have coexpression of magnitude under 0.5 with all targets. *fucR* has moderate coexpression (0.52) and coexpression rank (37) with its target *fucA*, but these were not strong enough for validation. Overall, although validation by coexpression has a higher FDR, coexpression can be used to validate predictions that are not validated by cofitness.

Discussion {#sec009}
==========

Advantages and limitations of use of fitness data {#sec010}
-------------------------------------------------

Although the fitness data statistically validated a subset of the regulatory predictions, it has several limitations compared to coexpression analysis. First, fitness data shows a correlation for a smaller fraction of TF-target pairs than expression data does \[[@pone.0178258.ref017]\]. In particular, cofitness analysis seems to be less effective for repressors. Although the characterized regulatory relationships in *E*. *coli* are roughly equally split between activators and repressors, most of the regulators that we validated had positive cofitness with their validated targets (78%). It appears that activators are much more likely to be cofit with a target than repressors are.

Second, fitness data measures changes in gene expression indirectly through its effects on growth, while the expression data does so directly. Nevertheless, cofitness seems to provide a stronger signal than coexpression, albeit for only a subset of the TF-target pairs. This was illustrated by the lower false discovery rate for "validating" known regulatory relationships in *E*. *coli* by cofitness as compared to coexpression.

Third, it is not possible to validate each TF-target pair by cofitness analysis because a TF's fitness pattern may be determined only by a small subset of targets. This makes it difficult to make novel TF-motif or TF-target predictions based solely on fitness data.

Fourth, given our statistical approach, we cannot validate TFs with over a certain number of targets. For example, for TFs with over 18 targets in *E*. *coli* (which has 3,789 genes with fitness data), even a (anti-)cofitness rank of 1 would yield p \> 0.01. For this reason, the cofitness analysis provides more powerful evidence for local TFs, which represent the vast majority of TFs in bacteria \[[@pone.0178258.ref022],[@pone.0178258.ref023]\].

Despite these limitations, there are some advantages to using the fitness data. First, cofitness analysis should be more robust than coexpression analysis if a TF and a non-target gene are coregulated by other factors. In this case, the two genes will be coexpressed, but they probably won't be cofit. Because the fitness data measures the effect of disabling each gene, regulation of the gene does not determine its fitness pattern. Second, cofitness analysis is advantageous for validating co-transcribed TF-target pairs. If a TF and its potential targets are co-transcribed and coexpressed, it is unclear whether the coexpression is caused by co-transcription or by a regulatory relationship. But in the absence of a regulatory relationship, there should not be any cofitness (although because of polar effects, this will not always be true in practice). More broadly, the above two points illustrate that fitness data may have an advantage in identifying direct regulatory relationships because it relies on mutants of the TF. Finally, fitness data is complementary to other large-scale data. For example, coexpression profiles and cofitness data seem to have complementary signals, as they have been shown to be poorly correlated \[[@pone.0178258.ref017]\]. Also, we found that in *E*. *coli*, there is little overlap between the characterized TFs that are "validated" by cofitness and by coexpression. The correlation may be poor because coexpression signals are expected to be weak for constitutively expressed TFs, while this is not expected for cofitness.

Fitness data may also be useful as a starting point for comparative genomics analyses. A significant fraction of putative TFs without comparative genomics predictions are cofit with at least one gene. For example, of 80 putative TFs (from the TF families in RegPrecise) that have no predictions in RegPrecise, 40 have significant phenotypes and of those, 24 have cofitness of over 0.8 or conserved cofitness of over 0.6, which are strong indications of a functional relationship \[[@pone.0178258.ref016]\]. Another 3 TFs had predictions that were not validated and have strong cofitness with other genes. The associations for these 27 TFs are listed in [S3 Table](#pone.0178258.s003){ref-type="supplementary-material"}. Although these putative pairs are not expected to be high-confidence at this stage, further analysis using comparative genomics could lead to high-confidence predictions.

Conclusions {#sec011}
-----------

Activating (or repressing) TFs tend to be cofit (or anti-cofit) with a subset of their targets. Based on this observation, we formulated a statistical method to validate TF-motif associations from comparative genomics predictions. The method was applied to RegPrecise predictions and 158 TFs in 107 ortholog groups were validated with a false discovery rate of 3.0%. Most of these TFs were predicted as activators (124) or repressors (28) based on the sign of the cofitness. Although the statistical test has a low rate of false positives due to random correlations, false positives could also arise from other sources, most notably polar effects. Nevertheless, validation by cofitness has several advantages over and is complementary to the use of other large-scale data.

Methods {#sec012}
=======

Data {#sec013}
----

We obtained known TF-target pairs in *E*. *coli* from RegulonDB version 9.1, downloaded on April 7, 2015 \[[@pone.0178258.ref019]\]. Version 4.0 of RegPrecise was downloaded on April 29, 2016 \[[@pone.0178258.ref013]\]. In RegPrecise predictions, each ortholog group has a unique regulog ID. Fitness data was obtained from <http://genomics.lbl.gov/supplemental/bigfit/> and data from April 29, 2016 was used \[[@pone.0178258.ref016]\]. Coexpression data was obtained from the Many Microbe Microarrays Database on July 7, 2015 \[[@pone.0178258.ref021]\].

Propagating regulatory predictions to orthologs {#sec014}
-----------------------------------------------

Predictions were propagated from each organism with RegPrecise predictions to each organism with fitness data. In order to propagate predictions from one organism to another, we ran ublast \[[@pone.0178258.ref024]\] between protein sequences of their genomes in both directions with thresholds E ≤ 10^−5^, identity ≥ 50%, and coverage ≥ 80%. A gene was considered a potential ortholog of another gene if they were best-scoring hits of each other. Orthologous TF-target pairs are pairs of genes where one gene is an ortholog of the TF and another is an ortholog of the target. If a TF of interest had multiple orthologs with predictions in RegPrecise, we chose just one bacterium to propagate from. We considered only bacteria that had at least one orthologous-TF pair (that is, there was at least one target with an ortholog in the bacterium of interest), and among those, we chose the bacterium whose TF was the most similar to the TF of interest (i.e., the highest bit score). Then, for each orthologous TF-target pair, we searched for the motif of the original TF around the target using Patser \[[@pone.0178258.ref010]\]. We identified the best-scoring hit found within 250 bp of the upstream end of each potential operon that the target ortholog belongs to, where potential operons were any series of adjacent genes that are on the same strand and less than 250 bp apart. A p-value for the motif hit was calculated by identifying the best motif hit for every gene in the genome and computing the fraction of genes that score at least as well as the target; genes in the same potential operon as the target ortholog were excluded. An orthologous TF-target pair was considered a propagated prediction if there is a motif hit with p≤0.01. There were significant motif hits for 56% of orthologous TF-target pairs from RegPrecise.

Cofitness bias correction {#sec015}
-------------------------

Pairs of closely located genes tend to have slightly higher cofitness values than gene pairs that are far apart. This bias might arise from the effect of chromosomal position on DNA copy number; the fitness values are normalized to this trend \[[@pone.0178258.ref015]\], but a small bias may remain. Since TFs are often near their targets, cofitness values of TF-target pairs were corrected to account for this bias. To estimate the bias for each genome, we sampled 1,000 gene pairs that are at most 20KB apart and 1,000 gene pairs that are at least 50KB apart or are on a different scaffold. The median cofitness value for each set was computed. If the closely located pairs have higher median cofitness than the pairs that are far apart, the bias was estimated to be the difference in the median fitness. Otherwise, the bias was estimated as 0. The median and maximum bias among all 25 bacteria were 0.02 and 0.07. We corrected for the bias in positively cofit TF-target pairs that are at most 20 kb apart by subtracting the bias from the original cofitness value. The cofitness rank was calculated based on this corrected cofitness.

Hypothesis testing {#sec016}
------------------

The rank-based p-value quantifies the probability of getting a cofitness rank or an anti-cofitness rank as extreme as the observed value, given the number of targets. For each transcription factor, the rank-based p-values for activators and repressors were calculated as follows: $$\begin{array}{l}
{r_{activator} = 2 \cdot \lbrack 1 - {(1 - R/(N - 1))}^{T}\rbrack} \\
{r_{repressor} = 2 \cdot \lbrack 1 - {(1 - R'/(N - 1))}^{T}\rbrack} \\
\end{array}$$ where *N* is the number of genes with fitness data in the genome, *R* is the top cofitness rank of the targets, *R'* is the top anti-cofitness rank, and *T* is the number of targets not including the TF. The above p-values were calculated assuming sampling with replacement. However, their values are very close to the corresponding probabilities assuming sampling without replacement since *T\<\<N* (*N* is 1,899 to 6,384). Since we tested for two signs, rank-based p-values include the factor of 2 for Bonferroni correction. In addition, to ensure thatthe value of cofitness is statistically significant, the p-values for the most positive and negative cofitness values were computed by using Fisher\'s transformation, from these z-scores: $$z = \frac{1}{2\sqrt{M - 3}}\ln\left( \frac{1 + r}{1 - r} \right)$$ where *r* is the (corrected) cofitness and *M* is the number of fitness values for each gene. The resulting *p*-values were corrected for testing both signs and for testing across multiple target genes by Bonferroni correction. Finally, the overall *p*-values for activators and repressors are calculated as follows: $$\begin{matrix}
{p_{activator} = max\left( {f_{activator},\ r_{activator}} \right)} \\
{p_{repressor} = max\left( {f_{repressor},\ r_{repressor}} \right)} \\
\end{matrix}$$ where and *f*~*activator*~ and *f*~*repressor*~ are Fisher transformation p-values. We used a threshold of *p* ≤ 0.01.

Only TFs with significant phenotypes \[[@pone.0178258.ref016]\] were tested. In most bacteria, a gene has a significant phenotype if \|fitness\|\>0.5 and \|t\|\>4 for some condition. These thresholds are adjusted upwards as needed to ensure that the FDR for detecting significant phenotypes is under 5% in each bacterium \[[@pone.0178258.ref016]\].

Although our hypothesis tests consider both the rank and the value of the cofitness, the test on the rank is more important in practice. For example, if we test only for activating relationships, and consider the 97 characterized TFs in RegulonDB that have significant phenotypes, then 82 of them have significant cofitness with a target (*factivator* ≤ *0*.*01*), but just 15 have a significant rank for the top target (*ractivator* ≤ *0*.*01)*. And all of those 15 TFs with a significant rank have significant cofitness as well. Our impression is that the fitness data has strong biological patterns that leads to significant correlations for genes that do not have a close functional relationship, but the genes with a highest cofitness rank are more likely to have a close relationship. Also note that, since these two hypothesis tests are correlated, we estimate the number of false positives and the FDR as if we were doing a single test with *p* ≤ 0.01.

Correctness of the hypothesis test {#sec017}
----------------------------------

To show that our *p* values are on the correct scale, we randomly selected new \"targets\" for the 228 transcription factors from 8 organisms that had significant phenotypes and had predictions in RegPrecise. We maintained the same number of targets with fitness data for each TF, and we repeated the procedure 10 times to give 2,280 cases. We computed *pactivator* and *prepressor* and we asked how often the smaller of these two *p*-values were below 0.01 or 0.05. We observed *p* ≤ 0.01 in 9 of the 2,280 cases (0.4%) and P ≤ 0.05 in 131 cases (5.8%). This confirms that our *p* values are on the correct scale and that our estimates of the false discovery rate are reasonable.

Analysis of polar effects {#sec018}
-------------------------

A prediction whose TF is co-transcribed with a putative target is potentially affected by polar effects. Validation rates were compared between predictions with potential polar effects and others. Only TFs with a significant phenotype and at least one target with fitness data were considered. We computed the fraction of validated TFs in the two sets of predictions and used the two-proportion z-test to construct a 95% confidence interval for the difference.

Putative TFs and potential targets {#sec019}
----------------------------------

Putative TFs were identified from genes that belong to the same TIGRFAMs as TFs in RegPrecise predictions \[[@pone.0178258.ref025]\]. (The list of putative TFs is not complete.) TIGRFAMs without DNA binding domains were manually filtered out in the analysis. Across the 25 genomes, we found 80 unpredicted putative TFs. We then sought to identify a potential target for each putative TF. We considered all genes that the putative TFs are not predicted to regulate in RegPrecise and the orthologous predictions. The potential target is the gene with the highest cofitness with the putative TF, out of genes that have conserved cofitness \> 0.6 and conserved cofitness rank ≤ 10 with the putative TF, or that have cofitness \> 0.8. (Conserved cofitness \> 0.6 if the two genes have cofitness \> 0.6 and an orthologous pair also has cofitness \> 0.6.) Otherwise, a potential target was not identified for the putative TF.

Statistical tools {#sec020}
-----------------

Statistical analyses were done with R version 3.1.1. Cofitness distributions were smoothed using the density function with default parameters. Code and an R image including the data are available at <http://genomics.lbl.gov/supplemental/cofittf/> or at <https://doi.org/10.6084/m9.figshare.5005004.v1>.

Supporting information {#sec021}
======================

###### List of transcription factors validated in original predictions.

(TAB)

###### 

Click here for additional data file.

###### List of transcription factors validated in orthologous predictions.

(TAB)

###### 

Click here for additional data file.

###### Potential TF-target pairs identified by cofitness.

(TAB)

###### 

Click here for additional data file.
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